SCM
TEVA icon

Sio Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sio Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,349,274
Closed -$24.3M – 58
2024
Q3 		$24.3M Buy
+1,349,274
New +$23.6M 9.64% 3
2021
Q2 		– Sell
-539,947
Closed -$6.23M – 96
2021
Q1 		$6.23M Sell
539,947
-150,439
-22% -$1.73M 1.26% 26
2020
Q4 		$6.66M Sell
690,386
-261,305
-27% -$2.5M 1.36% 23
2020
Q3 		$8.57M Sell
951,691
-11,105
-1% -$117K 1.7% 20
2020
Q2 		$11.9M Buy
962,796
+390,115
+68% +$4.41M 3.46% 4
2020
Q1 		$5.14M Buy
+572,681
New +$5.87M 1.72% 19
2017
Q2 		– Sell
-69,500
Closed -$2.23M – 69
2017
Q1 		$2.23M Buy
+69,500
New +$2.37M 1.25% 25
2016
Q1 		– Sell
-42,610
Closed -$2.8M – 51
2015
Q4 		$2.8M Buy
+42,610
New +$2.63M 1.24% 26

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Sio Capital Management's TEVA Position: Q4 2024 in Review

Sio Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 1,349,274 shares — an estimated $24.3M sold.

Sio Capital Management first reported a position in TEVA in Q4 2015 and held it in 8 quarters. The position peaked at $24.3M in Q3 2024. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Sio Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sio Capital Management sold 1,349,274 Teva Pharmaceuticals shares in Q4 2024, an estimated $24.3M.
  • Sio Capital Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 8 quarters.
  • Sio Capital Management's Teva Pharmaceuticals position peaked at $24.3M in Q3 2024.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Sio Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.